217 results on '"Protein C Inhibitor"'
Search Results
2. Treatment of GVHD in Hematopoietic Stem Cell Transplant (HSCT) Recipients Using AAT Plus Corticosteroids (CS) Compared With Corticosteroids Alone (BMT CTN 1705)
3. Protein C Inhibitor as a Diagnostic Marker: Immunohistochemical Expression in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia
4. Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
5. The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study (ACT)
6. Anti-inflammatory Therapy to Improve Outcomes After TPIAT
7. Evaluate Efficacy and Safety of "Kamada-AAT for Inhalation" in Patients With AATD (InnovAATe)
8. Maternal alpha1 Antitrypsin as a Marker of Intrauterine Growth Restriction in Pre-eclamptic Women
9. Aralast NP in Islet Transplant
10. COMPARISON OF PROTEIN C INHIBITOR (PCI) BLOOD LEVELS IN WOMEN BEFORE STARTING SECOND GENERATION ORAL CONTRACEPTIVE PILLS AND AFTER THREE MONTHS OF USE.
11. A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD
12. Safety Study of an Aerosolized, Recombinant Alpha 1-Antitrypsin in Subjects With Alpha 1-Antitrypsin Deficiency
13. Study of the Effect of Aerosolized, Recombinant Alpha 1-Antitrypsin on Epithelial Lining Fluid Analytes in Subjects With Alpha 1-Antitrypsin Deficiency
14. Alpha-1-Antitrypsin-Deficiency in COVID-19 (CORSAAR-AAT)
15. Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency
16. Trial of Alpha One Antitrypsin Inhalation in Treating Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
17. AKI Cardiosurgery Diagnostic Study (AKI-CDS) (AKI-CDS)
18. Effect of Double Dose of Alpha 1-antitrypsin Augmentation Therapy on Lung Inflammation.
19. Pilot Study of alpha1-antitrypsin to Treat Neuromyelitis Optica Relapses (A1AT for NMO)
20. A Pilot Study of Alpha-1-Antitrypsin (AAT) in Steroid Refractory Acute Graft vs Host Disease
21. Phase II Study to Evaluate the Efficacy and Safety of Glassia® in Type-1 Diabetes
22. Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
23. A Research Trial of Aralast in New Onset Diabetes (RETAIN) (RETAIN)
24. A common protein C inhibitor exosite partially controls the heparin induced activation and inhibition of serine proteases.
25. The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
26. Long Term Treatment Effect of the Safety, Tolerability and Efficacy of AAT in Type 1 Diabetes (AAT Extension)
27. Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus
28. Phase II Study of the Safety and Efficacy of Inhaled Alpha-1 Antitrypsin (AAT ) in Cystic Fibrosis Patients
29. Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction (VCU-Alpha1RT)
30. Safety and Tolerability Trial of Inhaled Alpha1-Proteinase Inhibitor (Human), Hydrophobic Chromatography Process (Alpha-1 HC) in Subjects With Cystic Fibrosis
31. Activated protein C assays: A review.
32. Comparison of Pharmacokinetic, Safety, Tolerability of Alpha-1 MP and Prolastin In Alpha1-antitrypsin Deficient Adults (ChAMP)
33. Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery
34. Safety and Efficacy of Inhaled Alpha-1 Antitrypsin in Preventing Bronchiolitis Obliterable Syndrome in Lung Transplant Recipients
35. Identification of novel diagnostic biomarkers for deep venous thrombosis.
36. Cell penetrating SERPINA5 (Protein C inhibitor, PCI): More questions than answers.
37. A simplified assay for the quantification of circulating activated protein C.
38. Phospholipid Binding Protein C Inhibitor (PCI) Is Present on Microparticles Generated In Vitro and In Vivo.
39. Host protein C inhibitor inhibits tumor growth, but promotes tumor metastasis, which is closely correlated with hypercoagulability.
40. Protein C Inhibitor (PCI) Binds to Phosphatidylserine Exposing Cells with Implications in the Phagocytosis of Apoptotic Cells and Activated Platelets.
41. Exendin-4 inhibits endothelial protein C receptor shedding in vitro and in vivo.
42. Novel anti-inflammatory function of NSC95397 by the suppression of multiple kinases.
43. Design, synthesis, and SAR of a series of activated protein C (APC) inhibitors with selectivity against thrombin for the treatment of haemophilia.
44. Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.
45. Targeted inhibition of activated protein C by a non-active-site inhibitory antibody to treat hemophilia
46. APC-PCI complex levels for screening of AAA in patients with peripheral atherosclerosis.
47. A reactive center loop-based prediction platform to enhance the design of therapeutic SERPINs
48. Diversity of Human Plasma Protein C Inhibitor
49. The APC-PCI concentration as an early marker of activation of blood coagulation: A study of women on combined oral contraceptives
50. Interaction of Protein C Inhibitor with the Type II Transmembrane Serine Protease Enteropeptidase.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.